Level Four Advisory Services LLC Invests $640,000 in Semler Scientific, Inc. (NASDAQ:SMLR)

Level Four Advisory Services LLC bought a new stake in Semler Scientific, Inc. (NASDAQ:SMLRFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,860 shares of the company’s stock, valued at approximately $640,000. Level Four Advisory Services LLC owned approximately 0.13% of Semler Scientific as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of SMLR. Global Retirement Partners LLC boosted its holdings in shares of Semler Scientific by 62.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after purchasing an additional 500 shares during the period. Sanctuary Advisors LLC raised its stake in shares of Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock valued at $261,000 after acquiring an additional 584 shares during the period. Jones Financial Companies Lllp bought a new stake in shares of Semler Scientific in the 4th quarter worth about $34,000. Larson Financial Group LLC purchased a new position in shares of Semler Scientific during the 4th quarter worth about $38,000. Finally, State Street Corp grew its holdings in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after purchasing an additional 725 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Down 0.2 %

Shares of Semler Scientific stock opened at $36.86 on Monday. The stock’s fifty day moving average is $45.47 and its two-hundred day moving average is $44.92. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56. The company has a market capitalization of $353.75 million, a PE ratio of 7.51 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLRGet Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $12.41 million for the quarter.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

Check Out Our Latest Stock Analysis on Semler Scientific

Semler Scientific Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Further Reading

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLRFree Report).

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.